First-in-Human PfSPZ-LARC2 Vaccination/CHMI
Clinical trial NCT06735209 · COMPLETED
Trial details
- NCT number
- NCT06735209
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-07-23
- Primary completion
- 2026-07-10
- Enrollment
- 22
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.